Boehringer Ingelheim to Present Early Clinical Data on SIRPα Inhibitors at ASCO 2025

Boehringer Ingelheim announced that it will present new clinical data from two early-stage trials investigating SIRPα inhibitors at the 2025 ASCO Annu...
Home/KnloSights/Clinical Trial Updates/Boehringer Ingelheim to Present Early Clinical Data on SIRPα Inhibitors at ASCO 2025